Ulotaront 【Ulotaront】U.S. Phase 3 Studies Failed. What’s Next? / Clinical Trial Data
Introduction The results of the Phase 3 trials of Ulotaront were released in July 2023. Two Phase 3 trials were both fai...
Ulotaront
Ulotaront Ulotaront A lot of benefits of taking【Ulotaront】: A new antipsychotic drug
Introduction Ulotaront acts as a TAAR1 agonist and a 5HT1A receptor agonist. I found a review article that describes the...
Ulotaront 【Ulotaront part 2】Phase 2 trial was successful. / Clinical Trial Data
Introduction In Part2, I will write about the efficacy of Ulotaront, one of the most anticipated antipsychotic drugs of ...
Ulotaront 【Ulotaront part 1】Promising TAAR1 agonist
Introduction I have written several times that I am most excited about muscarinic agonists such as KarXT, Emraclidine, a...